Neurological diseases and metabolism
Moving in bioRxiv, Nature Chemical Biology, Cell Host & Microbe, EMBO Reports, Frontiers in Genetics, medRxiv and Nature Biotechnology.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 9
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Neurological diseases and metabolism
Newest first · last 60 days
Twenty noncanonical cytochrome P450 families lacking a conserved cysteine ligand are identified in diverse microbial genomes, including the first native selenocysteine-ligated CYP.
A novel XK c.484C > T (p.Gln162Ter) variant is linked to McLeod syndrome in a Chinese Han family, expanding the genetic and ethnic spectrum of the disease.
- Open access
Exogenous CoA acts as a weak TLR4 agonist that enhances IL-4 driven macrophage activation via MyD88 in vitro and in vivo.
- Open access
Gut-derived pantothenic acid from Bacteroides fragilis improves metabolic syndrome by restoring gut barrier function and reducing inflammation.
Growth-coupled biosynthesis in Pseudomonas putida achieves gram-scale xanthommatin production by linking pigment synthesis to C1 metabolism, reaching significant bioproduction levels.
- Open access
- 11 cites
Browse JClub
Journals this month
- bioRxiv6131
- medRxiv1703
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
